Warning! GuruFocus detected
1 Severe warning sign
with 4170.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Vectorite Biomedical Inc
ISIN : TW0004170006
Description
Vectorite Biomedical Inc is a Taiwan-based biotechnology research and development, cell product (preparation) manufacturing and immune cell collection and storage business.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 16.68 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.5 | |||||
3-Year EBITDA Growth Rate | 56.2 | |||||
3-Year EPS without NRI Growth Rate | 53 | |||||
3-Year FCF Growth Rate | 63.2 | |||||
3-Year Book Growth Rate | 13.2 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.83 | |||||
9-Day RSI | 55.92 | |||||
14-Day RSI | 52.29 | |||||
3-1 Month Momentum % | -4.53 | |||||
6-1 Month Momentum % | -7.43 | |||||
12-1 Month Momentum % | -9.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.86 | |||||
Quick Ratio | 15.73 | |||||
Cash Ratio | 15.22 | |||||
Days Inventory | 106.24 | |||||
Days Sales Outstanding | 29.9 | |||||
Days Payable | 14.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.07 | |||||
Operating Margin % | -46.65 | |||||
Net Margin % | -37.74 | |||||
FCF Margin % | -24.75 | |||||
ROE % | -4.7 | |||||
ROA % | -4.48 | |||||
ROIC % | -10.34 | |||||
3-Year ROIIC % | -144.56 | |||||
ROC (Joel Greenblatt) % | -13.41 | |||||
ROCE % | -5.69 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.77 | |||||
PB Ratio | 1.39 | |||||
Price-to-Tangible-Book | 1.46 | |||||
EV-to-EBIT | -15.35 | |||||
EV-to-EBITDA | -23.91 | |||||
EV-to-Revenue | 7.15 | |||||
EV-to-FCF | -28.43 | |||||
Price-to-Net-Current-Asset-Value | 3 | |||||
Price-to-Net-Cash | 3.35 | |||||
Earnings Yield (Greenblatt) % | -6.52 | |||||
FCF Yield % | -2.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vectorite Biomedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 53.473 | ||
EPS (TTM) (NT$) | -0.46 | ||
Beta | -0.05 | ||
3-Year Sharpe Ratio | -0.08 | ||
3-Year Sortino Ratio | -0.17 | ||
Volatility % | 98.2 | ||
14-Day RSI | 52.29 | ||
14-Day ATR (NT$) | 0.642095 | ||
20-Day SMA (NT$) | 12.7125 | ||
12-1 Month Momentum % | -9.27 | ||
52-Week Range (NT$) | 10.4 - 21.1 | ||
Shares Outstanding (Mil) | 43.77 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vectorite Biomedical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vectorite Biomedical Inc Stock Events
Event | Date | Price (NT$) | ||
---|---|---|---|---|
No Event Data |
Vectorite Biomedical Inc Frequently Asked Questions
What is Vectorite Biomedical Inc(ROCO:4170)'s stock price today?
The current price of ROCO:4170 is NT$13.15. The 52 week high of ROCO:4170 is NT$21.10 and 52 week low is NT$10.40.
When is next earnings date of Vectorite Biomedical Inc(ROCO:4170)?
The next earnings date of Vectorite Biomedical Inc(ROCO:4170) is .
Does Vectorite Biomedical Inc(ROCO:4170) pay dividends? If so, how much?
Vectorite Biomedical Inc(ROCO:4170) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |